Superfoods in Supplement Form: Are They Worth It?
A 2025 market worth over $200 billion sells concentrated greens, berries, and algae in capsules, but only a few compounds like curcumin and berberine clear the evidence bar.
Methylene Blue and Cancer: What the Preclinical Research Shows
Methylene blue, an FDA-approved drug for methemoglobinemia, is being studied in preclinical cancer research for its redox-cycling, ROS, and PDT mechanisms.
